Sapporo Clinical Laboratory Inc. (TSE:9776) announces a share repurchase program. Under the offer, the company will repurchase 232,100 shares, representing 6.97% of its share capital for ¥209.12 million. The company will repurchase its shares at a price of ¥901 per share.

The company will repurchase its shares in order to implement a flexible capital policy in response to changes in the business environment. The offer is valid till March 26, 2024. As of February 26, 2024, the company had 3,330,578 shares in issue (excluding treasury stock) and 885,422 shares in treasury.